Page last updated: 2024-12-08

6-carboxyfluorescein diacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID151095
SCHEMBL ID5277430
MeSH IDM0246850

Synonyms (24)

Synonym
6-carboxyfluorescein diacetate, ~95% (hplc)
6-carboxyfluorescein diacetate
6-carboxyfluoresceine diacetate
C-1830
3',6'-diacetyloxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carboxylic acid
6-carboxy-3',6'-diacetylfluorescein
spiro(phthalan-1,9'-xanthene)-6-carboxylic acid, 3',6'-dihydroxy-3-oxo-, diacetate
6-cfda
spiro(isobenzofuran-1(3h),9'-(9h)xanthene)-6-carboxylic acid, 3',6'-bis(acetyloxy)-3-oxo-
3348-03-6
AKOS016008567
3',6'-diacetoxy-3-oxo-3h-spiro[isobenzofuran-1,9'-xanthene]-6-carboxylic acid
6-carboxy-di-o-acetylfluorescein
FT-0621011
SCHEMBL5277430
CS-3853
HY-D0721
mfcd00036871
DTXSID80187121
QMOGCCYGOPYYNT-UHFFFAOYSA-N
AS-32997
A853835
PD063613
C3710
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (23.08)18.2507
2000's10 (38.46)29.6817
2010's10 (38.46)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.87 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index22.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]